NKGen Biotech, Inc. (NKGN)
OTCMKTS · Delayed Price · Currency is USD
0.0200
+0.0090 (81.82%)
Oct 17, 2025, 2:06 PM EDT
NKGen Biotech Market Cap
NKGen Biotech has a market cap or net worth of $1.37 million as of October 17, 2025. Its market cap has decreased by -95.00% in one year.
Market Cap
1.37M
Enterprise Value
54.17M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since August 4, 2023, NKGen Biotech's market cap has decreased from 338.09M to 1.37M, a decrease of -99.60%. That is a compound annual growth rate of -91.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2025 | 1.37M | -94.20% |
| Dec 31, 2024 | 23.60M | -60.80% |
| Dec 29, 2023 | 60.19M | -82.20% |
| Aug 4, 2023 | 338.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 749.94M |
| Elite Pharmaceuticals | 652.54M |
| Veradigm | 514.01M |
| Nika Pharmaceuticals | 495.49M |
| CytoDyn | 365.33M |
| Northwest Biotherapeutics | 360.44M |
| Silence Therapeutics | 301.35M |
| American Oncology Network | 291.58M |